Last updated: November 2, 2023
Sponsor: Xuesong Li
Overall Status: Active - Recruiting
Phase
N/A
Condition
Urothelial Cancer
Treatment
Kidney sparing surgery+Postoperative radiotheray
Radical surgery
Clinical Study ID
NCT06120387
LUXUS3.0
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Ureteral cancer patients with high-risk factors (high-risk factors define multifocal;G3; T2-4); surgery may be performed with patients undergoing partial terminal ureteralresection or radical nephroureterectomy 2)Age ≥18 years; 3)Completion of abdominopelvic CT 4 weeks before enrollment to exclude distant metastasis and regional lymph node metastasis.
- Patients did not have other malignant neoplastic diseases in the last 5 years except fornon-melanoma of the skin and ductal carcinoma in situ of the breast; Willing to participatein perfecting the necessary examinations and follow-up for the sake of the study, andwilling to provide written informed consent.
Exclusion
Exclusion Criteria:
- Distant metastasis or retroperitoneal lymph node metastasis (N+) had been detectedat the time of surgery; R2 resection patients; history of bladder cancer; 2) Historyof pelvic and abdominal radiotherapy; history of inflammatory bowel disease; historyof systemic chemotherapy; 3) Pregnant women or breastfeeding women; or women ofchildbearing potential who are not practicing reliable contraception; (4) The presenceof active infections in those with pre-existing or coexisting bleeding disorders 5)clinically significant cardiac disease (e.g., hypertension controlled withmedications, unstable angina, New York Heart Association (NYHA) class ≥II congestiveheart failure, unstable symptomatic arrhythmias, or class ≥II peripheral vasculardisease); 6) Psychological, family, and social factors leading to lack of informedconsent.
Study Design
Total Participants: 90
Treatment Group(s): 2
Primary Treatment: Kidney sparing surgery+Postoperative radiotheray
Phase:
Study Start date:
November 10, 2023
Estimated Completion Date:
November 09, 2028
Connect with a study center
Departmeng of Urology, Peking University First Hospital
Beijing,
ChinaActive - Recruiting
Department of Radiotherapy Oncology, Peking University First Hospital
Beijing,
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.